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Abstract 
The present study examined the effect of sodium arsenite, cadmium chloride, heat shock and the 
proteasomal inhibitors MG132, withaferin A and celastrol on heme oxygenase-1 (HO-1; also 
known as HSP32) accumulation in Xenopus laevis A6 kidney epithelial cells. Immunoblot analysis 
revealed that HO-1 accumulation was not induced by heat shock but was enhanced by sodium 
arsenite and cadmium chloride in a dose- and time-dependent fashion. Immunocytochemistry 
revealed that these metals induced HO-1 accumulation in a granular pattern primarily in the 
cytoplasm. Additionally, in 20% of the cells arsenite induced the formation of large HO-1-
containing perinuclear structures. In cells recovering from sodium arsenite or cadmium chloride 
treatment, HO-1 accumulation initially increased to a maximum at 12 h followed by a 50% 
reduction at 48 h. This initial increase in HO-1 levels was likely the result of new synthesis as it 
was inhibited by cycloheximide. Interestingly, treatment of cells with a mild heat shock enhanced 
HO-1 accumulation induced by low concentrations of sodium arsenite and cadmium chloride. 
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Finally, we determined that HO-1 accumulation was induced in A6 cells by the proteasomal 
inhibitors, MG132, withaferin A and celastrol. An examination of heavy metal and proteasomal 
inhibitor-induced HO-1 accumulation in amphibians is of importance given the presence of toxic 
heavy metals in aquatic habitats.  
 
Key Words: heat shock proteins, sodium arsenite, cadmium chloride, amphibian, confocal 
microscopy, molecular chaperone, frog  
 
Introduction 
 
Sodium arsenite and cadmium chloride are toxic heavy metals that can have deleterious effects on 
vertebrates ranging from fish and amphibians to man. At the organismal level, sodium arsenite is 
associated with an increased risk of renal, hepatic and cardiovascular cancers (Del Razo et al., 
2001). Cadmium, which accumulates mainly in liver, kidney and reproductive tissues, is labeled a 
category one human carcinogen due to its implication in various cancers (Waisberg et al., 2003; 
Bonham et al., 2003; Barbier et al., 2004; Mouchet et al., 2006; Mendez-Armenta and Rios, 2007). 
Both arsenite and cadmium can be found in ground water originating from natural and 
anthropogenic sources (Del Razo et al., 2001; Waisberg et al., 2003). At the cellular and molecular 
level, both arsenite and cadmium toxicity were shown to increase the production of free radicals 
and reactive oxygen species (ROS) as well as induce metabolic abnormalities, cytoskeletal damage, 
DNA damage, apoptosis, formation of abnormal proteins and a dysregulation of gene expression 
(Chou, 1989; Li and Chou, 1992; Liu et al., 2001; Bode and Dong, 2002; Del Razo et al., 2001; 
Waisberg et al., 2003; Mouchet et al., 2007; Mendez-Armenta and Rios, 2007; Blechinger et al., 
2007). Both sodium arsenite and cadmium chloride treatment were also found to inhibit the 
ubiquitin-proteasome system (UPS), which plays a major role in the degradation of cellular protein 
through ATP-dependent hydrolysis (Lee and Goldberg, 1998; Kirkpatrick et al., 2003; Awasthani 
and Wagner, 2005; Yu et al., 2008; Brunt et al., 2012). This system is responsible for the removal 
of the majority of damaged proteins in the cell. 
Previously, it was reported that exposure of mammalian cells to sodium arsenite or cadmium 
chloride induced the expression of a number of genes that can ameliorate the effects of the heavy 
metals including those encoding heat shock proteins (HSPs) and heme oxygenase-1 (HO-1, also 
known as HSP32; Del Razo et al., 2001; Waisberg et al., 2003). HSPs are classified as molecular 
chaperones since they are involved in the folding and translocation of cellular proteins (Morimoto, 
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1998; Katschinski, 2004; Morimoto, 2008). They are grouped into at least six families based on size 
including HSP110, HSP90, HSP70, HSP60, HSP40, and the small HSPs (sHSPs). HSPs are 
generally highly conserved, and have been found in organisms ranging from bacteria to humans. 
Under stressful conditions, stress-inducible HSPs prevent the aggregation of unfolded proteins. 
Additionally, they contribute to protein refolding once the stress is alleviated and are involved in 
the degradation of proteins damaged beyond repair. Stress-induced accumulation of HSPs is 
primarily mediated by the trans-acting regulatory factor, heat shock factor 1 (HSF1), and the cis-
acting heat shock element (HSE) located in the promoter region of hsp genes.   
HO-1, which is involved in heme metabolism, also plays a role in the protection of cells against 
oxidative stress, likely through the effects of its catalytic by-products (Takeda et al., 1995; 
Gozzelino et al., 2010; Correa-Costa et al., 2012). For example, bilirubin is a potent antioxidant 
since it can scavenge ROS (Morita et al., 1997). Furthermore, HO-1 was detected at high levels in 
prostate and brain tumours, where it appears to have a cytoprotective effect (Maines and 
Abrahamsson, 1996; Hara et al., 1996; Fang et al., 2004). It was suggested that inhibition of HO-1 
may be beneficial in treating cancer as HO-1 catalytic by-products were found to have an anti-
apoptotic and angiogenic effect, contributing to the vascularisation of tumours (Brouard et al., 
2000; Deshane et al., 2007). Also, induction of HO-1 has been associated with neurological 
disorders such as Alzheimer’s, Huntington’s, and Parkinson’s disease (Smith et al., 1994; Schipper 
et al., 1998; Pappolla et al., 1998). Sodium arsenite and cadmium chloride have each been shown to 
induce the accumulation of HO-1 in mammalian cells (Masuya et al., 1998; Fauconneau et al., 
2002; Lee et al., 2005; Miyamoto et al., 2009; Teng et al., 2013). It was suggested that these metals 
induce oxidative damage that results in the enhanced expression of the ho-1 gene mediated through 
the Maf recognition elements (MARE) / nuclear factor-erythroid 2 family member (Nrf2) and p38 
mitogen-activated protein kinase (p38 MAPK) pathways (Elbirt et al., 1998; Alam et al., 2000; Lau 
et al., 2012). Additionally, cadmium chloride-induced ho-1 gene expression may involve the 
cadmium response element (CdRE), as well as the transcription factors HSF1 and pescadillo 
(Sikorski et al., 2006; Koizumi et al., 2007). 
Amphibians, given their aquatic habitat, are sensitive to the presence of sodium arsenite or 
cadmium chloride in their environment. For example, in the South African clawed frog, Xenopus 
laevis, sodium arsenite induced malformations during embryogenesis and metamorphosis and 
caused alterations in F-actin cytoskeletal structure in cultured cells (Gornati et al., 2000; Gellalchew 
and Heikkila, 2005; Davey et al., 2008). Also, cadmium was determined to have toxic and 
genotoxic effects during Xenopus development that included ocular anomalies, bent notochord and 
	   4	  
heart kidney, ovary and gut dysplasia and altered thyroid activity (Plowman et al., 1994; Mouchet et 
al., 2006; Sharma and Patino, 2008). Finally, both sodium arsenite and cadmium chloride induced 
the accumulation of Xenopus HSPs, including the small HSP family HSP30, as well as the 
inhibition of proteasome activity as indicated by an increase in the level of ubiquitinated protein and 
a decrease in chymotrypsin-like activity (Gordon et al., 1997; Lang et al., 2000; Gornati et al., 
2002; Heikkila, 2004; Gellalchew and Heikkila, 2005; Voyer and Heikkila, 2008; Woolfson and 
Heikkila, 2009; Young et al., 2009; Heikkila, 2010; Brunt et al., 2012). In contrast to HSPs, there is 
no available data, to the best of our knowledge, on the effects of sodium arsenite or cadmium 
chloride on HO-1 accumulation in amphibian model systems. In fact, information regarding the 
expression of the ho-1 gene is limited to a single report examining its constitutive expression during 
early embryogenesis of Xenopus laevis (Shi et al., 2008).  
In the present study, we examined the effect of heat shock, sodium arsenite and cadmium chloride 
treatment of Xenopus laevis A6 kidney epithelial cells on HO-1 accumulation and localization by 
immunoblot and immunocytochemical analysis, respectively. The levels of HO-1 were compared to 
HSP30, which was previously shown by our laboratory to be induced by all of the stressors in this 
study. Furthermore, we investigated the effect of a mild heat shock in conjunction with sodium 
arsenite or cadmium chloride exposure. Given the previous finding that these metals can inhibit 
proteasomal activity in A6 cells (Brunt et al., 2012), we examined the effect of the proteasomal 
inhibitors MG132, withaferin A and celastrol on HO-1 accumulation and localization.  
 
2. Materials and Methods  
 
2.1. Maintenance and treatment of Xenopus laevis A6 kidney epithelial cells 
 X. laevis A6 kidney epithelial cells were obtained from the American Type Culture Collection 
(CCL-102; Rockville, MD, USA). Cells were cultured in 70% Leibovitz (L)-15 media (Sigma-
Aldrich, Oakville, ON, Canada) and supplemented with 10% fetal bovine serum, 100 units/mL 
penicillin and 100 µg/mL streptomycin (all from Sigma-Aldrich) at 22 °C in T75 cm2  BD Falcon 
tissue culture flasks (VWR International, Mississauga, ON). Flasks containing cells that had 
achieved a confluency of 80-90% were used for experiments. Cells were maintained at 22 °C or 
subjected to heat shock at 30, 33 or 35 °C for 2 h followed by a 2 h recovery at 22 °C. Additionally, 
cells were incubated with 5 to 50 µM sodium arsenite, 10 to 200 µM cadmium chloride, 5 to 30 µM 
MG132 (carbobenzoxy–L-leucyl–L-leucyl–L-leucinal; dissolved in dimethylsulphoxide (DMSO; 
both from Sigma-Aldrich; Young and Heikkila, 2010), 1 to 10 µM withaferin A (dissolved in 
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DMSO; Enzo Life Sciences, Plymouth Meeting, PA; Khan et al., 2012) or 1 to 7.5 µM celastrol 
(dissolved in DMSO; Cayman Chemical, Ann Arbor, MI, USA; Walcott and Heikkila, 2010) at 22 
°C. In time course experiments, cells were treated with 30 µM sodium arsenite, 100 µM cadmium 
chloride, 30 µM MG132, 5 µM withaferin A or 2.5 µM celastrol at 22 °C for periods of time 
ranging from 0 to 48 h. In recovery experiments, cells were treated with sodium arsenite for 24 h 
followed by removal of media, rinsing of the flasks with media and incubation in fresh media for 0 
to 48 h. Some cells recovering from sodium arsenite treatment were also incubated with 100 µM 
cycloheximide (CHX; dissolved in water; Sigma-Aldrich) for the duration of the recovery period at 
22 °C. In experiments that combined a mild heat shock with chemical treatment, sodium arsenite, 
cadmium chloride were added to flasks of cells at the indicated concentrations and then incubated in 
a heated water bath at 30 °C for 12 h. Following treatment, media was removed, and cells were 
rinsed with 2 mL of 65% Hank’s balanced salt solution (HBSS; Sigma-Aldrich) followed by the 
addition of 1 mL 100% HBSS. Cells were detached from the flask by scraping and then transferred 
to a 1.5 mL microcentrifuge tube. Cells were pelleted by means of centrifugation for 1 min at 
21,920 g. The pelleted cells were stored at -80 °C prior to protein isolation. 
 
2.2. Protein isolation and immunoblot analysis 
The isolation of protein from A6 cells was performed as previously described (Young et al., 2009). 
Protein quantification was performed utilizing the bicinchoninic acid (BCA) method following the 
manufacturer’s protocol (Pierce, Rockford, IL, USA). Protein separation employing SDS-PAGE 
and transfer of proteins to nitrocellulose membrane was performed as previously described (Young 
et al., 2009; Khamis and Heikkila, 2013). The membranes were incubated with rabbit anti-HO-1 
antibody (1:500, Enzo Life Sciences, Farmingdale, NY), rabbit anti-Xenopus HSP30 antibody 
(1:1000; Fernando and Heikkila, 2000), or rabbit anti-actin polyclonal antibody (1:200, Sigma-
Aldrich). The nitrocellulose membranes were then incubated with alkaline phosphatase-conjugated 
goat anti-rabbit (BioRad, 1:3000 dilution). For detection, the membrane was incubated in alkaline 
phosphatase buffer (100 mM Tris base, 100 mM NaCl, 50 mM MgCl2 (pH 9.5)), 0.3% 4-nitro blue 
tetrazolium (NBT; Roche Diagnostics, Mississauga, ON, Canada), and 0.17% 5-bromo-4-chloro-3-
indolyl phosphate, toluidine salt (BCIP; Roche Diagnostics) until the bands were visible. Image J 
software (Version 1.46) was used to perform densitometric analysis within the range of linearity on 
all blots, with experiments performed at least in triplicate. The average values obtained were 
graphed as a percentage of the maximum value of either HO-1 or HSP30 bands. Vertical error bars 
display the standard error of the mean. Statistical analysis was performed on normalized data using 
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a one-way analysis of variance (ANOVA) with a Tukey’s post-test (p<0.05; indicated by *) to 
determine if statistically significant differences existed between samples. 
 
2.3. Immunocytochemistry and laser scanning confocal microscopy (LSCM) 
Immunofluorescence analyses were performed as detailed previously (Young et al., 2009; Khan et 
al., 2012). A6 cells were cultured on glass coverslips in sterile petri dishes at 22 °C for 24 h. The 
cells were then incubated at 33 °C for 2 h followed by a 2 h recovery at 22 °C or incubated with 
either 10 µM sodium arsenite, 100 µM cadmium chloride, 20 µM MG132, 2.5 µM celastrol, or 5 
µM withaferin A at 22 °C for 24 h. After treatment, L-15 media was removed and the cells were 
washed twice in phosphate-buffered saline (PBS; 1.37 M NaCl, 67 mM Na2HPO4, 26 mM KCl, 
14.7 mM H2PO4, 1 mM CaCl2, 0.5 mM MgCl2, pH 7.4) and the coverslips were transferred to new 
small petri dishes. Fixation of the cells was carried out with 3.7% paraformaldehyde in PBS (BDH 
Inc., Toronto, ON, Canada) for 15 min. Cells were rinsed 3 times for 5 min with PBS and then 
permeabilized with 0.3% Triton X-100 (Sigma-Aldrich) in PBS for 10 min followed by three 
washes with PBS. A6 cells were incubated with 3.7% (w/v) filtered bovine serum albumin (BSA) 
fraction V in PBS (Fisher Scientific, Ottawa, ON, Canada) for 1 h. Cells were then incubated with 
either affinity-purified rabbit anti-Xenopus HSP30 (1:500) or anti-HO-1 (1:200) antibody in 3.7% 
BSA for 1 h. Cells were washed 3 times with PBS for 2 min each. Indirect labeling was carried out 
in the dark for 30 min with fluorescent-conjugated goat anti-rabbit Alexa Fluor 488 (Molecular 
Probes, Eugene, OR, USA) in BSA at a 1:2000 dilution. After washing 3 times with PBS for 3 min 
each, cells were incubated with rhodamine-tetramethylrhodamine-5-isothiocyanate phalloidin 
(TRITC; 1:100; Molecular Probes) for 15 min to visualize the actin cytoskeleton. After washing 3 
times with PBS, coverslips were dried and mounted on a microscope slide with Vectashield 
mounting medium (Vector Laboratories Inc., Burlingame, CA), which contained 4,6-diamidino-2-
phenylindole (DAPI; Vector Laboratories Inc.) for the staining of nuclei. The slides were blotted 
dry and clear nail polish was used as an adhesive to bind coverslips to glass microscope slides. 
Slides were stored at 4 °C for a minimum of 1 h or until required. Cells were visualized using a 
Zeiss Axiovert 200 confocal microscope with Zen 2009 software (Carl Zeiss Canada Ltd., 
Mississauga, ON, Canada). Images were viewed with Zen 2009 Light Edition software.  
 
Results 
 
3.1. Characterization of heme oxygenase-1 (HO-1) protein in Xenopus laevis  
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The X. laevis putative HO-1 amino acid (aa) sequence was derived from the nucleotide sequence of 
a HO-1 cDNA originally isolated from an oocyte cDNA library (Figure 1). X. laevis HO-1 is 291 aa 
in length with an estimated size of 33.5 kDa and includes 8 heme binding pocket residues and a 
heme ligand binding site at H28. A comparison of the percent identity of the X. laevis HO-1 aa 
sequence with HO-1 aa sequences from other selected organisms and the constitutive HO-2 from X. 
laevis is shown in Table 1. X. laevis HO-1 shares 91% identity with X. tropicalis HO-1 while the 
percent identity with other organisms including chicken, duck, human, mouse, alligator and 
zebrafish HO-1 ranged from 63 to 45%. However, when percent identity was determined for a 
particularly conserved region (P129-R186) of X. laevis HO-1, the percent identity ranged from 
100% identity with X. tropicalis HO-1 to 69% with zebrafish HO-1. This region contains 4 of the 8 
heme binding pocket residues and is indicated in Figure 1 with a dashed line. X. laevis constitutive 
HO-2 shared only 53% identity with HO-1 and 74% in the HO-1 conserved region. Since an anti-X. 
laevis HO-1 antibody was not available for immunoblot and immunocytochemical analysis, we 
utilized an antibody (Enzo Life Sciences, BML-HC3001) that was made against a synthetic peptide 
(DLSEALKEATKEVH) derived from a human HO-1 conserved sequence, which shared 100% 
identity with X. laevis HO-1 (Figure 1). Previous studies employed this anti-HO-1 antibody to study 
stress-induced HO-1 accumulation in human cells (Hock et al., 2004; Hanneken et al., 2006).  
 
3.2. Heme oxygenase-1 (HO-1) is not induced by heat shock  
Initially, the effect of heat shock on HO-1 accumulation in A6 cells was examined by immunoblot 
analysis. As shown in Figure 2, A6 cells exposed to 30, 33 or 35 °C for 2 h followed by a 2 h 
recovery period at 22 °C did not induce detectable HO-1 accumulation even after longer incubation 
times as shown in Figure 8A. In contrast, HSP30 accumulation was induced at all 3 temperatures, 
which is in agreement with our previous findings (Gellalchew and Heikkila, 2005). In these 
experiments, sodium arsenite, which enhanced the levels of both HO-1 and HSP30, was employed 
as a positive control since previous studies demonstrated that HO-1 accumulation was induced by 
sodium arsenite in murine, and human cells (Fauconneau et al., 2002; Gong et al., 2002).  
 
3.3. HO-1 accumulation is induced by sodium arsenite and cadmium chloride in a concentration- 
and time-dependent manner 
An examination of the effect of different concentrations of sodium arsenite for 24 h on HO-1 
accumulation in A6 cells revealed that HO-1 was detectable at 5 µM, peaked at 10 µM and then 
declined to lower levels at higher concentrations (Fig. 3A). Compared to maximum levels of HO-1 
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found with 10 µM sodium arsenite treatment, the levels of HO-1 accumulation at 5 µM was 79% 
while at 50 µM the level was reduced to 56% (Fig. 3B). HSP30 accumulation in A6 cells was first 
detected using 10 µM sodium arsenite with peak levels at 20 to 30 µM and a slight reduction at 50 
µM. In a comparable analysis with cadmium chloride, both HO-1 and HSP30 accumulation was 
detected in cells treated with 50 µM cadmium chloride, peaked at 100 µM and then declined to 
lower levels at 200 µM (Fig. 3C). Densitometric analysis determined that in comparison to cells 
treated with 100 µM cadmium chloride, the level of HO-1 accumulation at 50 and 200 µM were 81 
and 32% of maximal values, respectively, whereas HSP30 values at the same concentrations were 
54 and 73%, respectively (Fig. 3D).  
In time course studies with A6 cells subjected to 30 µM sodium arsenite, HO-1 and HSP30 
accumulation were first detectable at 8 h and then increased in a time-dependent manner until the 
final time point of 48 h (Fig. 4A). Densitometric analysis determined that at 8, 12, and 24 h, HO-1 
signal intensities were approximately 12, 30, and 85% of maximum, respectively (Fig. 4B). A 
similar temporal pattern was observed for HSP30. In cells treated with 100 µM cadmium chloride 
for 4 to 48 h, minimal levels of HO-1 and HSP30 accumulation were first detected at 8 h followed 
by a time-dependent increase up to 48 h (Fig. 4C). Densitometry indicated that the values of HO-1 
accumulation at 8, 12, and 24 h were 7, 44 and 49%, respectively, compared to the maximum value 
at 48 h (Fig. 4D). A similar phenomenon was noted with HSP30, except that a near maximal value 
of 92% was detected after 24 h of cadmium chloride treatment.  
The induction of HO-1 in A6 cells by sodium arsenite or cadmium chloride appears to involve de 
novo transcription and translation. For example, treatment of cells with the transcriptional inhibitor, 
actinomycin D, prior to sodium arsenite or cadmium chloride treatment inhibited the accumulation 
of HO-1 and HSP30 (Fig. 5A). Cycloheximide, an inhibitor of protein synthesis, likewise prevented 
sodium arsenite- and cadmium chloride-induced HO-1 and HSP30 accumulation (Fig. 5B).  
 
3.4. Cellular localization of sodium arsenite- and cadmium chloride-induced HO-1  
Immunocytochemistry was used to examine the effect of heat shock, sodium arsenite, and cadmium 
chloride on HO-1 localization in A6 cells. HO-1 was not detected under heat shock conditions (Fig. 
6) in contrast to HSP30, which was detected in approximately 85-100% of cells (data not shown). 
Approximately 80% of cells treated with 10 µM sodium arsenite for 24 h exhibited HO-1 
accumulation in a punctate pattern with enrichment in the perinuclear region of the cytoplasm. 
Interestingly, 20% of the sodium arsenite-treated cells displayed HO-1 accumulation in large 
perinuclear structures (white arrows). Similar to arsenite, cadmium chloride induced HO-1 
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accumulation in a granular pattern that was detected in approximately 80% of cells. In essentially 
all of the sodium arsenite- and cadmium chloride-treated cells, control-like actin stress fibers and an 
intact F-actin cytoskeleton were observed. However, a minor amount of membrane ruffling was 
noted in some cells subjected to each of the stressors.  
 
3.5. Examination of HO-1 accumulation in cells recovering from sodium arsenite 
The next phase of this study examined the levels of HO-1 accumulation during recovery of cells 
from 30 µM sodium arsenite for 24 h (Fig. 7A). The levels of HO-1 increased during recovery up to 
12 h followed by a decrease at 24 h and a 4-fold reduction at 48 h. Similar results were observed for 
the levels of HSP30, with an increase in accumulation from 0 to 12 h recovery, followed by a 
decrease in HSP30 accumulation after 24 h of recovery, and a 2-fold reduction after 48 h of 
recovery compared to maximal values. In order to monitor the decay pattern of HO-1 during 
recovery from sodium arsenite in the absence of translation, cycloheximide (CHX) was employed. 
As shown in Figure 7B, preincubation of cells with 100 µM CHX for 6 h completely inhibited the 
sodium arsenite-induced transient increase in accumulation of both HO-1 and HSP30 after 12 h of 
recovery such that the levels of these proteins decreased gradually over 48 h. These results show 
that the transient increase in HO-1 and HSP30 levels after incubation with sodium arsenite is due to 
new synthesis since inhibition of protein synthesis prevented this response.	  Similar results were 
obtained with A6 cells recovering from a 12 h treatment with 100 µM cadmium chloride treatment 
(data not shown).  
 
3.6. Mild heat shock enhanced sodium arsenite- and cadmium chloride-induced HO-1 accumulation  
Previous studies in our laboratory determined that elevated temperatures enhanced sodium arsenite- 
or cadmium chloride-induced HSP30 accumulation (Woolfson and Heikkila, 2009; Young et al., 
2009). Given these results we examined the effect of a mild heat shock on sodium arsenite- or 
cadmium chloride-induced upregulation of HO-1 levels in A6 cells. Treatment of cells with a mild 
heat shock of 30 °C for 12 h did not result in detectable levels of HO-1 or HSP30 (Fig. 8A). 
Furthermore, exposure of cells to 10 µM cadmium chloride for 12 h at 22 °C did not induce 
detectable levels of HO-1 or HSP30 although cadmium treatment at 30 °C did induce a slight 
increase in HO-1 levels to 3% of peak levels (Fig. 8B). Treatment of A6 cells with 10 µM sodium 
arsenite alone resulted in enhanced levels of HO-1 and HSP30 to 9% and 30%, respectively, of 
maximum levels. Compared to 10 µM sodium arsenite alone, the highest levels of HO-1 (3-fold) 
and HSP30 (11-fold) accumulation occurred in cells subjected to a mild heat shock plus sodium 
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arsenite. When cells were treated with sodium arsenite and cadmium chloride simultaneously at 22 
°C, HO-1 and HSP30 accumulation were 56% and 16% of the maximum values, respectively. 
 
3.7. Proteasomal inhibitors induced HO-1 accumulation in a concentration- and time-dependent 
manner 
Given our previous finding that sodium arsenite and cadmium chloride inhibited proteasomal 
activity and induced hsp30 gene expression (Brunt et al., 2012), we examined the effect of MG132, 
a well-characterized proteasomal inhibitor, on HO-1 accumulation in A6 cells. As shown in Figure 
9A, cells treated with MG132 displayed detectable levels of HO-1 accumulation at 5 µM, peaked at 
20 µM and reduced levels at 30 µM (Fig. 9A). Densitometric analysis indicated that HO-1 
accumulation at 5 µM MG132 was 33% of the maximal density, while 10 and 30 µM were 65 and 
53%, respectively (Fig. 9B). Accumulation of HSP30 induced by 5 µM MG132 was 59% of the 
maximum value, while the densities for 10 and 30 µM MG132 treatments were 87 and 68%, 
respectively. In time course studies employing 30 µM MG132, minimal HO-1 and HSP30 
accumulation was detected at 8 h followed by increased levels in a time-dependent manner up to 48 
h (Fig. 9C). Densitometric analysis determined that the levels of HO-1 accumulation at 8, 12, and 
24 h were 29, 66 and 87%, respectively, of the maximum density while for HSP30 the same time 
points exhibited densities of 16, 45, 76%, respectively, compared to peak values (Fig. 9D). As 
found with sodium arsenite and cadmium chloride, actinomycin D and cycloheximide pretreatment 
each inhibited HO-1 and HSP30 accumulation suggesting the involvement of de novo transcription 
and translation in their induction (data not shown). Finally, treatment of cells with a mild heat shock 
of 30 °C significantly enhanced MG132-induced accumulation of both HO-1 and HSP30 compared 
to cells treated at 22 °C (data not shown). 
Two other proteasomal inhibitors, withaferin A and celastrol, that were shown to induce HSP30 
accumulation (Walcott and Heikkila, 2010; Khan et al., 2012), also enhanced HO-1 accumulation in 
A6 cells. In preliminary dose-response experiments, maximal accumulation of HO-1 occurred with 
5 µM withaferin A and 2.5 µM celastrol (data not shown). In time course studies, HO-1 
accumulation was initially detected in cells treated with 5 µM withaferin A for 8 h with maximum 
levels at 16 h and a slight reduction at 24 h (Fig. 10A, B). In contrast to HO-1, maximum levels of 
HSP30 were found at 24 h. Additionally, celastrol-induced HO-1 and HSP30 accumulation 
occurred initially in cells treated with 2.5 µM celastrol for 8 h and maximal	  levels were observed in 
cells treated for 24 h (Fig. 10C). A 20-fold increase in HO-1 accumulation was observed in cells 
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treated for 16 h in comparison to 8 h. This was greater than the 4-fold increase observed with 
HSP30 during the same time period (Fig. 10D). 
 
3.8 Localization of HO-1 accumulation in response to selected proteasomal inhibitors 
Finally, immunocytochemistry was employed to examine the effect of MG132, withaferin A, and 
celastrol on HO-1 localization in A6 cells (Fig. 10). HO-1 was detected in a punctate pattern in 
approximately 65% of MG132-treated cells, while withaferin A and celastrol induced HO-1 
accumulation in 90 and 85% of cells, respectively. Proteasomal inhibitor-treated A6 cells generally 
displayed an intact F-actin cytoskeleton. However, in some cells treated with celastrol, we observed 
a rounded cell shape and disrupted actin cytoskeleton as indicated by F-actin localization to the cell 
periphery. It is possible that celastrol might inhibit nuclear factor kappaB (NF-κB), which is linked 
to decreased levels of cell adhesion molecules that are required for proper attachment of the 
cytoskeleton to the extracellular matrix (Collins et al., 1995; Tozawa et al., 1995). 
 
Discussion 
 
The present study has demonstrated that treatment of amphibian cells with heavy metals and 
proteasomal inhibitors but not heat shock induced the accumulation of HO-1. These findings are of 
significance given the contamination of numerous aquatic habitats with heavy metals and other 
toxins. Initial immunoblot and immunocytochemical studies determined that HO-1 accumulation in 
X. laevis A6 kidney epithelial cells was not induced by heat shock in contrast to HSP30. A lack of 
heat-inducibility with respect to HO-1 accumulation was reported in a variety of mammalian cell 
lines, including human alveolar macrophage, hepatoma, glioma, HeLa, fibroblast, erythroblast, and 
HL60 leukemia (Yoshida et al., 1988; Keyse and Tyrrell, 1989; Taketani et al., 1989; Mitani et al., 
1990; Okinaga et al., 1996). However, other studies reported that heat shock enhanced HO-1 
accumulation in rat liver, kidney, heart and brain as well as in murine Sertoli cells, human 
fibroblasts, and in rat and human hepatoma cell lines (Taketani et al., 1988; Keyse and Tyrrell, 
1989; Mitani et al., 1990; Raju and Maines, 1994; Lee et al., 1996; Bechtold and Brown, 2003). The 
mechanism(s) responsible for the differences in the heat inducibility of HO-1 accumulation in 
different cell types or tissues is not known. However, previous studies with a human erythroid cell 
line revealed that a HSE found in the regulatory region of the ho-1 gene was repressed, possibly by 
transcription factors that interacted with a downstream purine-rich region (Okinaga et al., 2006). 
While it is possible that this mechanism may account for the lack of heat shock induciblity of HO-1 
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accumulation in A6 cells, unfortunately the regulatory regions of the X.s laevis ho-1 gene have not 
been isolated and sequenced.  
Treatment of Xenopus A6 cells with the heavy metals sodium arsenite and cadmium chloride 
resulted in HO-1 accumulation in a dose- and time-dependent manner. Furthermore, heavy metal-
induced HO-1 accumulation was inhibited by actinomycin D, a transcriptional inhibitor, and by the 
translational inhibitor cycloheximide. Sodium arsenite was also found to induce HO-1 accumulation 
in chicken hepatoma cells as well as in the human cell lines, HeLa and HL60 leukemia (Taketani et 
al., 1989; Elbirt et al., 1998; Ryter et al., 2006). Furthermore, cadmium chloride-induced HO-1 
accumulation was documented in fish and mammalian systems (Taketani et al., 1989; Alam et al., 
2000; Ryter et al., 2006; Søfteland et al., 2010; Williams and Gallagher, 2013). Previous studies 
with mammalian cells reported that transcriptional activation of the ho-1 gene in response to 
oxidative damage to cellular protein induced by sodium arsenite or cadmium chloride treatment 
involved the Nrf2 pathway including the transcriptional repressor Bach1 (Alam et al., 2000; Suzuki 
et al., 2003; Waisberg et al., 2003; Galazyn-Sidorczuk et al., 2009). It was determined that 
treatment of cells with sodium arsenite inactivated Bach1 while cadmium chloride induced its 
export from the nucleus (Del Razo et al., 2001; Suzuki et al., 2003; Samuel et al., 2005; Reichard et 
al., 2008). In each situation the lack of a functional repressor resulted in the Nrf2-mediated 
activation of the ho-1 gene expression. Another possibility for the upregulation of ho-1 gene 
expression by cadmium chloride involves the binding of transcription factors to the cis-acting 
cadmium-responsive element (CdRE) found in the 5’ regulatory region (Takeda et al., 1995). In 
human renal epithelial cells the transcription factor pescadillo interacted specifically with the CdRE 
(Sikorski et al., 2006). Also, pescadillo overexpression increased the transcriptional activity of the 
human ho-1 gene promoter. Furthermore, it was suggested that in cadmium chloride-treated HeLa 
cells, HSF1 may interact with pescadillo bound to CdRE or with other transcription factors bound 
to adjacent regulatory elements resulting in an enhanced expression of the ho-1 gene (Koizumi et 
al., 2007). Finally, a study with mouse hepatoma cells suggested that cadmium-induced ho-1 gene 
expression might occur through stabilization of Nrf2 protein (Stewart et al., 2003).  Hopefully, 
future studies will determine whether these possible mechanism(s) for sodium arsenite- or cadmium 
chloride-induced ho-1 gene activation extend to Xenopus.  
The present study has shown that proteasomal inhibitors including MG132, withaferin A and 
celastrol induced HO-1 accumulation in A6 cells. While MG132-induced accumulation of HO-1 
was documented in mammalian cells, enhanced levels of HO-1 were induced by lower 
concentrations and at shorter time points than found with Xenopus A6 cells. For example, HO-1 
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was detectable in A6 cells after a 5 µM MG132 treatment for 24 h with higher levels from 10 to 30 
µM. In contrast, mouse astrocytes displayed elevated levels of HO-1 with only 1 µM MG132 after 2 
h (Chen and Regan, 2005; Cui et al., 2013). In the present study, two anti-inflammatory plant 
products, withaferin A and celastrol, which were previously shown to inhibit proteasomal activity 
and induce HSP30 in Xenopus A6 cells (Walcott and Heikkila, 2010; Khan et al., 2012), also 
induced HO-1 accumulation. In mammalian studies, withaferin A increased HO-1 accumulation in 
human choroidal endothelial cells while celastrol treatment induced ho-1 gene expression in rat 
vascular smooth muscle cells and cerebral cortical cultures and in a human keratinocyte cell line 
(Bargagna-Mohan et al., 2006; Yu et al., 2010; Seo et al., 2011; Chow et al., 2013). While the 
mechanism for proteasomal inhibitor induced accumulation of HO-1 in Xenopus cells is not known, 
a number of studies with mammalian cells proposed that proteasomal inhibitor-induced 
accumulation of HO-1 involves the transcription factor, Nrf2 (Wu et al., 2004; Yamamoto et al., 
2010). Previously, Wu et al. (2004) reported that MG132-induced accumulation of HO-1 in murine 
macrophages occurred through the activation of the p38-MAPK pathway. Subsequently, Kastle et 
al. (2012) determined that proteasomal inhibition induced the deacetylation of HDAC6 resulting in 
the subsequent phosphorylation of p38-MAPK and activation of the Nrf2 pathway. Finally, it was 
suggested that proteasomal inhibitors might enhance the stability of Nrf2 and prolong its activity by 
preventing its on-going degradation (Stewart et al., 2003; Martin et al., 2004).  
Immunocytochemical analysis of A6 cells confirmed the presence of HO-1 accumulation in 
response to sodium arsenite, cadmium chloride, MG132, withaferin A or celastrol treatment 
primarily in the perinuclear region in a punctate pattern. These results were expected since HO-1 is 
primarily an ER protein that is anchored to the endoplasmic reticulum by a single C-terminal 
transmembrane region (Ryter et al., 2006; Gottlieb et al., 2012).  Interestingly, large HO-1 
antibody-staining structures were detected in about 20% of cells treated with sodium arsenite 
treatment. In a recent study, it was determined that NADPH cytochrome P450 reductase can 
promote oligomerization of HO-1 into higher ordered complexes also containing biliverdin 
reductase (Huber et al., 2009; Linnenbaum et al., 2012). It is possible that a similar phenomenon 
may occur with HO-1 in A6 cells.  
Finally, the present study determined that incubation of A6 cells with low concentrations (10 µM) 
of sodium arsenite or cadmium chloride plus a concurrent mild heat shock (30 °C) enhanced the 
levels of HO-1 accumulation compared to the different stressors individually. Previously, it was 
reported that cellular uptake of both sodium arsenite and cadmium chloride increased with elevated 
temperatures in mammals and fish (McGeachy and Dixon, 1989; Souza et al., 1997; Saydam et al., 
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2003). Thus, it is possible that the mild heat shock may enhance the uptake of sodium arsenite, 
cadmium chloride or MG132 into A6 cells which may in turn increase their ability to activate the 
Nrf2 pathway thereby activating ho-1 gene expression as previously discussed. It is also tenable that 
the mild heat shock may have increased the amount of oxidative stress in A6 cells, which could 
further activate the Nrf2 pathway. 
 
In summary, the present study found that Xenopus HO-1 accumulation was induced by sodium 
arsenite, cadmium chloride and proteasomal inhibitors but not heat shock. Additional basic 
information regarding stress-induced HO-1 accumulation is of importance given that it has been 
implicated in a variety of diseases and conditions that are associated with oxidative stress or 
proteasomal inhibition, including Alzheimer’s disease, diabetes, atherosclerosis, and myocardial 
infarction (Takahashi et al., 2000; Juan et al., 2001; Turkseven et al., 2005; Liu et al., 2005). 
Additionally, aquatic organisms, including amphibians, are quite susceptible to the deleterious 
effects of toxicants such as sodium arsenite and cadmium chloride. Thus, HO-1 may be of value as 
a biomarker for studies involving environmental contamination by cadmium chloride, sodium 
arsenite or other agents. The present study has also shown that HO-1 accumulation by these metals 
was enhanced by mild heat shock. This last finding is of importance given the global rise in 
temperature over the last number of decades and its potential effect on aquatic organisms, especially 
those in contaminated lakes or rivers.  	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Figure Legends 
 
Figure 1. Amino acid sequence of Xenopus laevis HO-1. The X. laevis HO-1 protein (Genbank 
accession number: NP_001089909), which is 291 amino acids long has a putative heme ligand 
binding site, a conserved histidine residue (H28), that is indicated by an asterisk below the letter. 
The putative heme binding pocket residues are shown in a bold font and underlined. The HO-1 
antibody (Enzo Life Sciences) used in this study, which was produced against a synthetic human 
HO-1 peptide, shares 100% sequence identity with the corresponding X. laevis HO-1 amino acids 
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(D15-H28) indicated by the solid line. The conserved region that was compared with other 
organisms for shared identity in Table 1 is indicated with a dashed line spanning P129 to R186. 
 
Figure 2. Effect of heat shock on HO-1 accumulation. A6 cells were maintained at 22 °C (C) or 
incubated at 30, 33 or 35 °C for 2 h followed by a 2 h recovery at 22 °C. Some cells were also 
treated with 20 µM sodium arsenite (As) at 22 °C for 24 h. Cells were harvested and total protein 
was isolated. Forty micrograms of total protein was subjected to immunoblot analysis using anti-
HO-1, anti-HSP30 and anti-actin antibodies as described in Materials and methods. These results 
are representative of 3 separate experiments. 
 
Figure 3. Effect of different concentrations of sodium arsenite or cadmium chloride on HO-1 
accumulation. Cells were maintained at 22 °C (C) or incubated with 5, 10, 20, 30 or 50 µM sodium 
arsenite (As; panel A) or with 25, 50, 100 or 200 µM cadmium chloride (Cd; panel C) at 22 °C for 
24 h. After treatment, total protein was isolated and subjected to immunoblot analysis as detailed in 
Materials and methods. These results are representative of 3 separate experiments. Densitometric 
analysis of the band intensity for HO-1 (black) and HSP30 (white) employed Image J software 
(panels B and D). The results were expressed as a percentage of the maximum band intensity 
acquired for each protein in each trial (panel B: 10 µM As for HO-1 and 30 µM for HSP30; panel 
D: 100 µM Cd for both HO-1 and HSP30). Vertical error bars denote standard error. A one-way 
ANOVA with a Tukey’s Multiple Comparisons post-test was used to determine significance. 
Significant differences between the control cells and treated cells are indicated as * (p < 0.05).  
 
Figure 4. Time course of As- or Cd-induced HO-1 accumulation. Cells were maintained at 22 °C 
(C) or incubated with 30 µM As (panel A) or 100 µM Cd (panel C) at 22 °C for 4, 8, 12, 24 or 48 h. 
After treatment, total protein was isolated and analyzed by immunoblot analysis. These results are 
representative of 3 separate experiments. B) Densitometric analysis of the band intensity for HO-1 
(black) and HSP30 (white) utilized Image J software (panels B and D). The results were expressed 
as a percentage of the maximum band intensity acquired for each protein in each trial (panel B: 48 h 
for both HO-1 and HSP30; panel D: 48 h for both HO-1 and HSP30) as described in the legend of 
Figure 3. Significant differences between control and treated cells are indicated as * (p < 0.05). 
 
Figure 5. Effect of actinomycin D and cycloheximide treatment on As- and Cd-induced HO-1 
accumulation. A) Cells were incubated at 22 °C (C) or treated with 30 µM As or 100 µM Cd for 12 
h at 22 °C, with or without a 30 min pretreatment with 2 or 5 µg/mL actinomycin D. B) Cells were 
incubated at 22 °C (C) or treated with 30 µM As for 24 h or 100 µM Cd for 12 h at 22 °C, with or 
without a 6 h pretreatment with 100 µM cycloheximide (CHX). After these treatments, total protein 
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was isolated and subjected to immunoblot analysis as detailed in Materials and methods. These 
results are representative of 2 separate trials.  
 
Figure 6. Effect of heat shock, As or Cd on the cellular localization of HO-1. A6 cells were cultured 
on base-washed glass coverslips and then maintained at 22 °C (C), heat shocked at 33 °C for 2 h 
with 2 h recovery or treated with 10 µM As or 100 µM Cd for 24 h. Actin and nuclei staining 
utilized phalloidin conjugated to TRITC (red) or DAPI (blue), respectively. HO-1 was detected with 
rabbit anti-HO-1 antibody, and a secondary antibody conjugated to Alexa-488 (green). The 
columns, from left to right, show the fluorescence detection channels for actin, HO-1, and 
combined actin, DAPI, and HO-1, respectively. The laser scanning confocal microscopy (LSCM) 
procedure was followed as outlined in the Materials and methods. White arrows indicate the 
presence of large HO-1 staining complexes in As-treated cells. The 20 µm scale bars are indicated 
at the bottom right corner of each panel. 
 
Figure 7. HO-1 accumulation during recovery from As treatment in the absence or presence of 
cycloheximide. Cells were maintained at 22 °C (C) or subjected to 30 µM As treatment for 24 h and 
then allowed to recover for 0 to 48 h in fresh media at 22 °C in the absence (panel A) or presence of 
100 µM cycloheximide (CHX; panel B). After treatment, total protein was isolated and analyzed by 
immunoblotting as described in Materials and methods. Densitometric analysis of the band intensity 
for HO-1 (black) and HSP30 (white) employed Image J software as described in the legend of 
Figure 3. The results were expressed as a percentage of the maximum band intensity acquired with 
each protein in each trial (panel A: 12 h As recovery time point for HO-1 and HSP30; panel B: 0 h 
As recovery time point for HO-1 and 4 h for HSP30). In both panels A and B, the data are the 
results of 3 separate trials. Significant differences between the control cells and treated cells are 
indicated as * (p < 0.05). 
 
Figure 8. Effect of As or Cd on HO-1 accumulation with or without a mild heat shock. Cells were 
maintained at 22 °C (C) or incubated with 10 µM As or 10 µM Cd at either 22 or 30 °C for 12 h. In 
other experiments, cells were treated with 10 µM As and 10 µM Cd simultaneously at 22 °C for 12 
h.  After treatment, total protein was isolated and subjected to immunoblot analysis as described in 
Materials and methods. The data are representative of 3 separate experiments. Densitometric 
analysis of the band intensity for HO-1 (black) and HSP30 (white) utilized Image J software as 
mentioned in the legend of Figure 3. The results were expressed as a percentage of the maximum 
band intensity acquired for each protein in each trial (10 µM As plus 30 °C for both HO-1 and 
HSP30). Significant differences between the control cells and treated cells are indicated as * (p < 
0.05). 
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Figure 9. Effect of different MG132 concentrations and treatment times on HO-1 accumulation. 
Cells were maintained at 22 °C or incubated with 5, 10, 20, or 30 µM MG132 (panel A) at 22 °C 
for 24 h, or with 30 µM of MG132 at 22 °C for 0, 4, 8, 12, 24, or 48 h (panel C). Following 
treatment, total protein was isolated and subjected to immunoblot analysis. The immunoblots are 
representative of 3 separate experiments. In panels B and D, densitometric analysis of the band 
intensity for HO-1 (black) and HSP30 (white) employed Image J software. The results were 
expressed as a percentage of the maximum band intensity acquired for each protein in each trial 
(panel B: 20 µM MG132 for both HO-1 and HSP30; panel D: 48 h for both HO-1 and HSP30). 
Significant differences between the control cells and treated cells are indicated as * (p < 0.05). 
 
Figure 10. Withaferin A and celastrol induced HO-1 accumulation occurred in a time-dependent 
manner. Cells were maintained at 22 °C (C) or treated with 5 µM withaferin A (WA; panel A) or 
2.5 µM celastrol (CEL; panel B) for 2 to 24 h at 22 °C. Cells were harvested and total protein was 
isolated. Forty µg of the different protein samples were analyzed by immunoblot analysis as 
described in Material and methods. These data are representative of three separate experiments. 
Image J software was used to perform densitometric analysis of the signal intensity for HO-1 
(black) or HSP30 (white) protein bands as described in Materials and methods and the legend of 
Figure 3. The data are expressed as a percentage of the maximum signal (panel B: 5 µM WA for 16 
h for HO-1 or 5 µM WA for 24 h for HSP30; panel D: 2.5 µM celastrol for 24 h for HO-1 and 
HSP30). The standard error is represented by vertical error bars. Significant differences between the 
control and WA- or CEL-treated cells are indicated as * (p < 0.05).  
 
Figure 11. Effect of MG132, WA or CEL on the localization of HO-1 in A6 cells. Cells were 
cultured on base-washed glass coverslips and maintained at 22 °C (Control) or treated with 20 µM 
MG132, 2.5 µM CEL, or 5 µM WA at 22 °C for 24 h. Actin and nuclei were stained directly with 
phalloidin conjugated to TRITC (red) or DAPI (blue), respectively. HO-1 was indirectly detected 
with an anti-HO-1 antibody and a secondary antibody conjugated to Alexa-488 (green). From left to 
right the columns display fluorescence detection channels for actin, HO-1 and merger of actin, 
DAPI and HO-1. The 20-µm white scale bars are indicated at the bottom right section of each panel. 
These results are representative of 3 different experiments. 
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Table 1. A comparison of Xenopus laevis HO-1, HO-2, and selected HO-1 homologues from other 
vertebrates. 
 
Protein / Species % identity  
(complete amino acid 
sequence) 
% identity  
(conserved 
region) 
HO-1 / Xenopus tropicalis 91 100 
HO-1 / Gallus gallus 63 91 
HO-1 / Anas platyrhynchos 63 91 
HO-1 / Homo sapiens 61 88 
HO-1 / Mus musculus 59 84 
HO-1 / Alligator mississipiensis 58 88 
HO-2 / Xenopus laevis 53 74 
HO-1 / Danio rerio 45 69 
 
The sequences were obtained from the GenBank database (www.ncbi.nlm.nih.gov). The NCBI 
reference sequences of the proteins are: Xenopus laevis HO-1, NP_001089909; Xenopus tropicalis 
HO-1, XP_002934766; Gallus gallus HO-1, ADK26061; Anas platyrhynchos HO-1, 
XP_005015402; Homo sapiens HO-1, ADZ76424; Mus musculus HO-1, EDL10826; Alligator 
mississipiensis HO-1, XP_006261961; Xenopus laevis HO-2, NP_001085675, and Danio rerio 
HO-1, NP_001120988. The percent identity of a highly conserved region (residues P129 – R186 in 
Xenopus laevis HO-1) was also determined using these data. This domain is indicated with a dashed 
line in Figure 1. 
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